nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—Danazol—Prednisone—multiple sclerosis	0.217	0.267	CrCrCtD
Trilostane—Progesterone—Prednisolone—multiple sclerosis	0.155	0.191	CrCrCtD
Trilostane—Methyltestosterone—Prednisone—multiple sclerosis	0.155	0.191	CrCrCtD
Trilostane—Methyltestosterone—Prednisolone—multiple sclerosis	0.151	0.186	CrCrCtD
Trilostane—Testosterone—Prednisolone—multiple sclerosis	0.135	0.166	CrCrCtD
Trilostane—HSD3B1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.0152	0.0885	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.0152	0.0885	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.0115	0.0671	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.0115	0.0671	CbGpPWpGaD
Trilostane—HSD3B1—Glucocorticoid biosynthesis—POMC—multiple sclerosis	0.0106	0.0619	CbGpPWpGaD
Trilostane—HSD3B1—Androgen biosynthesis—POMC—multiple sclerosis	0.00823	0.048	CbGpPWpGaD
Trilostane—HSD3B2—Glucocorticoid biosynthesis—POMC—multiple sclerosis	0.00804	0.0469	CbGpPWpGaD
Trilostane—HSD3B2—Androgen biosynthesis—POMC—multiple sclerosis	0.00624	0.0363	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.00342	0.0199	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00308	0.018	CbGpPWpGaD
Trilostane—Danazol—CCL2—multiple sclerosis	0.00267	0.443	CrCbGaD
Trilostane—HSD3B2—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.00259	0.0151	CbGpPWpGaD
Trilostane—ESR2—Ovarian Infertility Genes—PGR—multiple sclerosis	0.0025	0.0146	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptors—PGR—multiple sclerosis	0.00218	0.0127	CbGpPWpGaD
Trilostane—ESR2—Ovarian Infertility Genes—VDR—multiple sclerosis	0.00175	0.0102	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.00173	0.0101	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—TLR4—multiple sclerosis	0.00172	0.01	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—IL23A—multiple sclerosis	0.00165	0.00964	CbGpPWpGaD
Trilostane—Danazol—PGR—multiple sclerosis	0.00162	0.27	CrCbGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00156	0.00907	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00156	0.00907	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptors—VDR—multiple sclerosis	0.00153	0.00889	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—POMC—multiple sclerosis	0.0015	0.00877	CbGpPWpGaD
Trilostane—HSD3B1—cerebellum—multiple sclerosis	0.00144	0.17	CbGeAlD
Trilostane—ESR2—Validated nuclear estrogen receptor alpha network—PGR—multiple sclerosis	0.00144	0.00838	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—TLR4—multiple sclerosis	0.0013	0.00758	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.00128	0.00746	CbGpPWpGaD
Trilostane—HSD3B2—nervous system—multiple sclerosis	0.00122	0.143	CbGeAlD
Trilostane—ESR2—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.00121	0.00703	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00118	0.00688	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00118	0.00688	CbGpPWpGaD
Trilostane—HSD3B2—central nervous system—multiple sclerosis	0.00117	0.138	CbGeAlD
Trilostane—HSD3B2—Corticotropin-releasing hormone—POMC—multiple sclerosis	0.00114	0.00664	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—IL2—multiple sclerosis	0.00111	0.00648	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptors—PGR—multiple sclerosis	0.0011	0.00641	CbGpPWpGaD
Trilostane—ESR1—Nuclear signaling by ERBB4—PGR—multiple sclerosis	0.00108	0.00628	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000988	0.00576	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—SRM—multiple sclerosis	0.000984	0.00573	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000971	0.00566	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000971	0.00566	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—SELE—multiple sclerosis	0.00095	0.00553	CbGpPWpGaD
Trilostane—HSD3B2—brain—multiple sclerosis	0.000929	0.11	CbGeAlD
Trilostane—ESR1—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.00087	0.00507	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—TGFB1—multiple sclerosis	0.000868	0.00506	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—MAPK1—multiple sclerosis	0.000851	0.00496	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—IL2—multiple sclerosis	0.000843	0.00491	CbGpPWpGaD
Trilostane—Progesterone—PGR—multiple sclerosis	0.000842	0.14	CrCbGaD
Trilostane—ESR1—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000776	0.00452	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptors—VDR—multiple sclerosis	0.000769	0.00448	CbGpPWpGaD
Trilostane—ESR2—brainstem—multiple sclerosis	0.000757	0.0892	CbGeAlD
Trilostane—HSD3B2—Metabolism—SRM—multiple sclerosis	0.000746	0.00435	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—PGR—multiple sclerosis	0.000725	0.00423	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CYP27B1—multiple sclerosis	0.000693	0.00404	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CYP24A1—multiple sclerosis	0.000693	0.00404	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—MMP9—multiple sclerosis	0.000691	0.00402	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000678	0.00395	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.000663	0.00386	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—TGFB1—multiple sclerosis	0.000657	0.00383	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—MAPK1—multiple sclerosis	0.000645	0.00376	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GPC5—multiple sclerosis	0.000634	0.0037	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000608	0.00354	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000532	0.0031	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	0.000529	0.00308	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP24A1—multiple sclerosis	0.000525	0.00306	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP27B1—multiple sclerosis	0.000525	0.00306	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—RRM1—multiple sclerosis	0.000525	0.00306	CbGpPWpGaD
Trilostane—ESR1—brainstem—multiple sclerosis	0.000519	0.0611	CbGeAlD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000514	0.00299	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000502	0.00293	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000498	0.0029	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.00049	0.00285	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GPC5—multiple sclerosis	0.000481	0.0028	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000479	0.00279	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—ZNF746—multiple sclerosis	0.000475	0.00277	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL10—multiple sclerosis	0.000459	0.00267	CbGpPWpGaD
Trilostane—ESR1—Estrogen signaling pathway—MAPK1—multiple sclerosis	0.000447	0.0026	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL4—multiple sclerosis	0.000446	0.0026	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PTBP1—multiple sclerosis	0.000435	0.00253	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000427	0.00249	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	0.00042	0.00245	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	0.000408	0.00238	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000408	0.00238	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—HLA-A—multiple sclerosis	0.000404	0.00236	CbGpPWpGaD
Trilostane—ESR2—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	0.0004	0.00233	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—RRM1—multiple sclerosis	0.000398	0.00232	CbGpPWpGaD
Trilostane—ESR2—nervous system—multiple sclerosis	0.000397	0.0468	CbGeAlD
Trilostane—Methyltestosterone—ALB—multiple sclerosis	0.000386	0.0641	CrCbGaD
Trilostane—ESR2—central nervous system—multiple sclerosis	0.000382	0.045	CbGeAlD
Trilostane—ESR2—cerebellum—multiple sclerosis	0.000373	0.044	CbGeAlD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000366	0.00213	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PGR—multiple sclerosis	0.000363	0.00212	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—CD28—multiple sclerosis	0.000353	0.00206	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.00035	0.00204	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—MMP9—multiple sclerosis	0.000348	0.00203	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—HNRNPA1—multiple sclerosis	0.00033	0.00192	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—U2AF2—multiple sclerosis	0.00033	0.00192	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000319	0.00186	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CCL2—multiple sclerosis	0.000317	0.00185	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—IFNG—multiple sclerosis	0.000309	0.0018	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000309	0.0018	CbGpPWpGaD
Trilostane—ESR2—brain—multiple sclerosis	0.000303	0.0357	CbGeAlD
Trilostane—HSD3B1—Metabolism—BCHE—multiple sclerosis	0.000302	0.00176	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—PGR—multiple sclerosis	0.000298	0.00174	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—MYC—multiple sclerosis	0.000282	0.00164	CbGpPWpGaD
Trilostane—Estradiol—ALB—multiple sclerosis	0.000279	0.0463	CrCbGaD
Trilostane—ESR1—LKB1 signaling events—MYC—multiple sclerosis	0.000277	0.00161	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—IFNG—multiple sclerosis	0.000276	0.00161	CbGpPWpGaD
Trilostane—ESR1—nervous system—multiple sclerosis	0.000272	0.032	CbGeAlD
Trilostane—ESR1—AP-1 transcription factor network—IFNG—multiple sclerosis	0.00027	0.00157	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000268	0.00156	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000265	0.00155	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000262	0.00153	CbGpPWpGaD
Trilostane—ESR1—central nervous system—multiple sclerosis	0.000262	0.0308	CbGeAlD
Trilostane—ESR2—Gene Expression—ZFP36L1—multiple sclerosis	0.000261	0.00152	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000257	0.0015	CbGpPWpGaD
Trilostane—ESR1—cerebellum—multiple sclerosis	0.000256	0.0301	CbGeAlD
Trilostane—ESR1—Signaling by ERBB4—CD86—multiple sclerosis	0.000252	0.00147	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000251	0.00147	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—IL2—multiple sclerosis	0.000245	0.00143	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.000244	0.00142	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000242	0.00141	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL2—multiple sclerosis	0.00024	0.0014	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—ZNF746—multiple sclerosis	0.00024	0.0014	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—BCHE—multiple sclerosis	0.000229	0.00133	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—IL1B—multiple sclerosis	0.000228	0.00133	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—MMP9—multiple sclerosis	0.000227	0.00132	CbGpPWpGaD
Trilostane—Testosterone—ALB—multiple sclerosis	0.000224	0.0372	CrCbGaD
Trilostane—ESR1—Gene Expression—PTBP1—multiple sclerosis	0.000219	0.00128	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000215	0.00126	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—MAPK1—multiple sclerosis	0.00021	0.00123	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—VDR—multiple sclerosis	0.000208	0.00121	CbGpPWpGaD
Trilostane—ESR1—brain—multiple sclerosis	0.000208	0.0245	CbGeAlD
Trilostane—ESR2—Gene Expression—PABPC1—multiple sclerosis	0.000202	0.00118	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	0.000201	0.00117	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—MYC—multiple sclerosis	0.000192	0.00112	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—TGFB1—multiple sclerosis	0.000191	0.00112	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—STAT3—multiple sclerosis	0.000191	0.00111	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—MAPK1—multiple sclerosis	0.000188	0.00109	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—MYC—multiple sclerosis	0.000188	0.00109	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TGFB1—multiple sclerosis	0.000187	0.00109	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000184	0.00107	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—CD80—multiple sclerosis	0.000184	0.00107	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000182	0.00106	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—RPL5—multiple sclerosis	0.000182	0.00106	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—APOE—multiple sclerosis	0.000182	0.00106	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—MAPK1—multiple sclerosis	0.000174	0.00101	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	0.000167	0.000972	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	0.000167	0.000971	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—HNRNPA1—multiple sclerosis	0.000166	0.000969	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—U2AF2—multiple sclerosis	0.000166	0.000969	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	0.000166	0.000969	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	0.000163	0.00095	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—IL6—multiple sclerosis	0.000162	0.000942	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—POMC—multiple sclerosis	0.000156	0.000909	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	0.000155	0.000904	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—TYK2—multiple sclerosis	0.000155	0.000903	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—PGR—multiple sclerosis	0.00015	0.000876	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000147	0.000858	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PGR—multiple sclerosis	0.000143	0.000836	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ALB—multiple sclerosis	0.000142	0.000829	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL6—multiple sclerosis	0.000141	0.000822	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—APOE—multiple sclerosis	0.000138	0.000802	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—ZFP36L1—multiple sclerosis	0.000131	0.000766	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—LINGO1—multiple sclerosis	0.000125	0.000726	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—POMC—multiple sclerosis	0.000118	0.000689	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TAGAP—multiple sclerosis	0.000108	0.00063	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ALB—multiple sclerosis	0.000108	0.000628	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—VDR—multiple sclerosis	0.000105	0.000612	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PABPC1—multiple sclerosis	0.000102	0.000594	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	0.000101	0.000591	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—VDR—multiple sclerosis	0.0001	0.000584	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	9.92e-05	0.000578	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—MAPK1—multiple sclerosis	9.87e-05	0.000575	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—S1PR1—multiple sclerosis	9.44e-05	0.00055	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—RPL5—multiple sclerosis	9.19e-05	0.000535	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GPC5—multiple sclerosis	9.19e-05	0.000535	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	8.4e-05	0.00049	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	8.38e-05	0.000488	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—MYC—multiple sclerosis	8.28e-05	0.000482	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	8.22e-05	0.000479	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RGS1—multiple sclerosis	8.03e-05	0.000468	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	7.82e-05	0.000456	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GPR65—multiple sclerosis	7.61e-05	0.000444	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—IL6—multiple sclerosis	7.58e-05	0.000442	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PGR—multiple sclerosis	7.23e-05	0.000422	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCR1—multiple sclerosis	6.96e-05	0.000406	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CXCL13—multiple sclerosis	6.96e-05	0.000406	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—VDR—multiple sclerosis	5.05e-05	0.000295	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCL3—multiple sclerosis	4.96e-05	0.000289	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PTGER4—multiple sclerosis	4.78e-05	0.000278	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PGR—multiple sclerosis	4.7e-05	0.000274	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CXCR3—multiple sclerosis	4.61e-05	0.000269	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CD28—multiple sclerosis	4.57e-05	0.000266	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCR2—multiple sclerosis	4.49e-05	0.000261	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—MYC—multiple sclerosis	4.17e-05	0.000243	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CNR1—multiple sclerosis	4.14e-05	0.000241	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—MYC—multiple sclerosis	3.98e-05	0.000232	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CXCL10—multiple sclerosis	3.73e-05	0.000217	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CD86—multiple sclerosis	3.26e-05	0.00019	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCL5—multiple sclerosis	3.21e-05	0.000187	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SPP1—multiple sclerosis	2.97e-05	0.000173	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCR5—multiple sclerosis	2.89e-05	0.000169	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL2RA—multiple sclerosis	2.85e-05	0.000166	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APOE—multiple sclerosis	2.63e-05	0.000153	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CD80—multiple sclerosis	2.38e-05	0.000139	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—POMC—multiple sclerosis	2.26e-05	0.000132	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCL2—multiple sclerosis	2.21e-05	0.000129	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—MYC—multiple sclerosis	2.01e-05	0.000117	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TYK2—multiple sclerosis	2.01e-05	0.000117	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL2—multiple sclerosis	1.67e-05	9.74e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MMP9—multiple sclerosis	1.58e-05	9.21e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—STAT3—multiple sclerosis	1.41e-05	8.19e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MYC—multiple sclerosis	1.31e-05	7.61e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TGFB1—multiple sclerosis	1.3e-05	7.59e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MAPK1—multiple sclerosis	1.28e-05	7.45e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL6—multiple sclerosis	9.82e-06	5.72e-05	CbGpPWpGaD
